SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-05-173739
Filing Date
2005-08-24
Accepted
2005-08-24 13:13:58
Documents
4
Period of Report
2005-08-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 20013
2 SEVERANCE AGREEMENT AND RELEASE OF ALL CLAIMS dex101.htm EX-10.1 28423
3 PRESS RELEASE dex991.htm EX-99.1 6896
4 GRAPHIC g96740ex99_1.jpg GRAPHIC 3092
  Complete submission text file 0001193125-05-173739.txt   61419
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 051045516
SIC: 2834 Pharmaceutical Preparations